scholarly journals PCN5 PHARMACOECONOMIC ANALYSIS OF SORAFENIB AND SUNITINIB FOR FIRST LINE TREATMENT OF METASTATIC RENAL CELL CARCINOMA (MRCC) COMPARED WITH COMBINATION THERAPY OF BEVACIZUMAB, GEMCITABINE, AND CAPECITABINE (BGC) AT A LARGE CANCER CENTER

2007 ◽  
Vol 10 (3) ◽  
pp. A124 ◽  
Author(s):  
WD Smith ◽  
R Arbuckle
Keyword(s):  
Renal Cell Carcinoma ◽  
Combination Therapy ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Pharmacoeconomic Analysis ◽  
Cancer Center ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

Pazopanib for the First-Line Treatment of Patients with Advanced and/or Metastatic Renal Cell Carcinoma

2012 ◽  
Vol 31 (1) ◽  
pp. 15-24 ◽  
Author(s):  
Mary Kilonzo ◽  
Jenni Hislop ◽  
Andrew Elders ◽  
Cynthia Fraser ◽  
Donald Bissett ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

Sunitinib First-line Treatment in Metastatic Renal Cell Carcinoma: Costs and Effects

2019 ◽  
Vol 39 (10) ◽  
pp. 5559-5564 ◽  
Author(s):  
RIIKKA-LIISA VUORINEN ◽  
NIINA PAUNU ◽  
TAINA TURPEENNIEMI-HUJANEN ◽  
TAINA REUNAMO ◽  
ANTTI JEKUNEN ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

First-line Treatment of Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: Systematic Review and Network Meta-analysis

2020 ◽  
Vol 18 (4) ◽  
pp. 244-251.e4 ◽  
Author(s):  
Fernando Sabino M. Monteiro ◽  
Andrey Soares ◽  
Márcio Debiasi ◽  
Fabio A. Schutz ◽  
Fernando Cotait Maluf ◽  
...  
Keyword(s):  
Systematic Review ◽  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Meta Analysis ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document